FRIENDS-01:A Multicenter Open-label Randomized Controlled Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
FRIENDS-01:A Multicenter Open-label Randomized Controlled Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11
Epistemonikos ID: 1ca82d3d8282ce99cfbb02470fda31385111d4de
First added on: Feb 01, 2025